Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5445 Journals
4170 Congresses
9600+ Unique Records

Cardiovascular & Hematological Disorders - Drug Targets


Title Abbreviation
Cardiovasc Hematol Disord Drug Targets
ISSN
1871-529X
Electronic ISSN
2212-4063
Readership
Cardiologists, Cardiovascular Surgeons, Hematologists, Pharmacologists, Scientists, Vascular Medicine Specialists
Scope
Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of in-depth/mini reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Bentham Science Publishers Ltd.
To see more details about Cardiovascular & Hematological Disorders - Drug Targets, Subscribe Now!
Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library